Remove Defibrillator Remove Electrophysiology Remove Sudden Cardiac Death
article thumbnail

PROPHYLACTIC ELECTROPHYSIOLOGIC INTERVENTIONS IN CONGENITAL HEART DISEASE: NEW INSIGHTS AND FRESH CONTROVERSY

HeartRhythm

Sustained MVT affects approximately 10% of such patients at 30 years after cardiac repair and is inextricably related to the burden of sudden cardiac death (SCD).(1)

article thumbnail

Smidt Heart Institute Sudden Cardiac Arrest Expert Receives 2024 Distinguished Scientist Award

DAIC

“I am grateful to my ACC colleagues for recognizing our work with this prestigious award,” said Chugh, associate director of the Smidt Heart Institute and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research at Cedars-Sinai. The credit goes to my mentees and colleagues over the years.

article thumbnail

Electrophysiological patterns and structural substrates of Brugada syndrome: Critical appraisal and computational analyses

Journal of Cardiovascular Electrophysiology

Abstract Brugada syndrome (BrS) is a cardiac electrophysiological disease with unknown etiology, associated with sudden cardiac death. Symptomatic patients are treated with implanted cardiac defibrillator, but no risk stratification strategy is effective in patients that are at low to medium arrhythmic risk.

article thumbnail

Oldest‐in‐Human Successful Extraction Experience of a Novel Substernal Extravascular Defibrillator

Journal of Cardiovascular Electrophysiology

ABSTRACT Introduction Substernal extravascular defibrillators (EV ICDs) have been shown to be effective and safe for patients at risk of sudden cardiac death, however, there is little evidence around the safety of extracting chronic devices.

article thumbnail

Slowly conducting anatomic isthmuses of tetralogy of Fallot: An opportunity for “prophylactic” ventricular tachycardia ablation

HeartRhythm

Patients with repaired tetralogy of Fallot are at risk of ventricular tachycardia (VT) and sudden cardiac death. Historically, risk stratification electrophysiologic studies involved programmed ventricular stimulation with VT induction guiding implantable cardioverter-defibrillator (ICD) implantation or VT ablation.

article thumbnail

The Future of Single Chamber ICDs: BIOTRONIK Takes Unprecedented Market Stance with Proprietary DX Technology

DAIC

5,6 “We are very proud that our DX technology provides the only lead available on the market offering both ventricular pacing/defibrillation and atrial monitoring,” said Ryan Walters, BIOTRONIK US President. Journal of Cardiovascular Electrophysiology, Volume 30, Issue 10, October 2019, Pages 1994–2001. 2023;12:e029126.

article thumbnail

Evaluation of patients with implantable cardioverter?defibrillator in a Latin American tertiary center

Journal of Cardiovascular Electrophysiology

Progressive decline across periods in mortality rates among patients with implantable cardioverter-defibrillator (ICD). Abstract Introduction Despite advancements in implantable cardioverter-defibrillator (ICD) technology, sudden cardiac death (SCD) remains a persistent public health concern.